A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, JV; Ratzan, SC; Palayew, A; Gostin, LO; Larson, HJ; Rabin, K; Kimball, S; El-Mohandes, A
NATURE MEDICINE
2021
VL / 27 - BP / 225 - EP / +
- DOI
abstract
Survey data from across 19 countries reveal heterogeneity in attitudes toward acceptance of a COVID-19 vaccine and suggest that trust in government is associated with vaccine confidence. Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 61.4% reported that they would accept their employer's recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer's advice to do so.
19th
Global
AccesS level
Green Published, Bronze
Mentions data
PAPER MENTIONS
Biology & Biochemistry
- 502
- Wikipedia
- 0
- News
- 348
- Policy
- 3
Molecular Biology & Genetics
- 502
- Wikipedia
- 0
- News
- 348
- Policy
- 3
Global Ranking
- 502
- Wikipedia
- 0
- News
- 348
- Policy
- 3
Clinical Medicine
- 502
- Wikipedia
- 0
- News
- 348
- Policy
- 3
Mentions Chart
Influratio by dimension
-
Twitter
-
Wikipedia
-
News
-
Policy
PAPER MENTIONS
- 502
- Wikipedia
- 0
- News
- 348
- Policy
- 3
Among papers in Biology & Biochemistry
Among papers in Molecular Biology & Genetics
Among papers in Global Ranking
18th
Influratio
2265
Among papers in Clinical Medicine
23rd
Influratio
2265